Phase 1 Study of 3D229 in Healthy Subjects

Clinical trial NCT04941313 · COMPLETED

Trial details

NCT number: NCT04941313
Sponsor: 3D Medicines
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2021-07-27
Primary completion: 2021-11-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.